Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Past hour
    • Any time
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

The Lancet54m
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial
Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

DOJ reaches deal w/ Boeing
8 found guilty in robbery
Diagnosed w/ brain disorder
Caught up in Trump's fight
Jones' husband dies
Agrees to plead guilty
Allows to shield DOGE docs
Convicted of manslaughter
Inmate escapes for 2nd time
Signs bill to protect parks
Signs nuclear energy orders
Delta stowaway found guilty
TN executes Oscar Smith
Reveals All-Defensive teams
Record floodwaters in AU
FTC drops PepsiCo lawsuit
'Avengers' movies delayed
Probes Media Matters
Trump threatens 25% tariff
Redbird to buy Telegraph
US indicts Russian man
Signs $45M+ rookie contract
Drops Swift subpoena
Violated civil rights law?
Hamburg stabbing
Judge halts Trump admin
RU-UKR begin prisoner swap
South Africa mine rescue
FTC withdraws lawsuit
Sues 4 New Jersey cities
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy